World Health Organization

A WHO guideline committee recommended against the use of remdesivir in patients hospitalized with COVID-19, regardless of how sick they are.

The Democratic Republic of the Congo’s 11th Ebola outbreak was declared over today, marking the end of a 6-month effort in Équateur province.

Globally, millions of people affected by tuberculosis are being diagnosed and treated with outdated tools, according to a new report from the Stop TB Partnership.

The WHO COVID-19 global literature database contained nearly 85,000 publications as of Sept. 23, but ophthalmologists are still working to discover patterns and effects the disease may have on eyes.

The Democratic Republic of the Congo has seen a twofold increase in Ebola cases in the last 5 weeks, bringing the total count to 100 in less than 100 days, according to WHO.

Researchers used county-level vaccination data and a model that distributed arriving travelers to counties near international airports to estimate the U.S. counties — and international travel routes — at highest risk for measles outbreaks.

The consumption of a group of first- and second-line antibiotics with a higher potential for resistance increased by approximately 91% between 2000 and 2015, according to a study in The Lancet Infectious Diseases.

The ongoing Ebola outbreak in the Democratic Republic of the Congo’s Équateur Province has surpassed the total number of cases recorded during the province’s last outbreak in 2018, according to data reported by WHO.

Two dozen biopharmaceutical companies recently announced the launch of the AMR Action Fund, a collaboration they hope will lead to the development of two to four new antibiotics by 2030.

Tenofovir alafenamide with emtricitabine and dolutegravir, or TAF/FTC+DTG, and tenofovir disoproxil fumarate, or TDF, and FTC+DTG resulted in similar efficacy to TDF, FTC and efavirenz, or EFV, among people with HIV in South Africa.